Entrada Therapeutics gains FDA clearance for its Phase 1b ELEVATE-44-102 study, evaluating ENTR-601-44 in adult Duchenne ...

Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with ...

Entrada Therapeutics (TRDA) announced that the United States Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and ...

Receives FDA authorization to initiate ELEVATE-44-102, a Phase 1b multiple ascending dose clinical study of ENTR-601-44 in adults living with Duchenne muscular dystrophy - - Follows recently received ...

Entrada Therapeutics is finally able to get its Duchenne muscular dystrophy candidate (DMD) back on track after the FDA ...

A naturalized citizen, along with other business leaders, are working to create new resources for undocumented people living ...

Kontoor Brands, Inc. (KTB), the VF-offshoot parent of the Wrangler and Lee brands, has signed a definitive agreement to ...

Entrada Therapeutics received clearance from the UK Medicines and Healthcare Products Regulatory Agency to initiate the ELEVATE-44-201 clinical trial of its lead candidate, ENTR-601-44.

Stylish women's laptop bags for 2025. Whether you're after a blush pink leather laptop holder or a chic black secure tote for ...

Virat Kohli hits century INDIA WIN BY 6 WICKETS Virat Kohli finishes off in style. He hits Khushdil Shah for a boundary to ...